IMAX gets Wedbush price target hike as growth outlook strengthens
IMAX (NYSE:IMAX) received a price target increase to $62 from Wedbush, citing stronger growth outlook. Wedbush raised its 2028 EBITDA estimate and applied a lower EV/EBITDA multiple. IMAX also raised its 2026 EBITDA margin guidance to 50% or more. Q3 revenue rose 64% to $175M, beating estimates, with EPS at $2.21. Wedbush expects continued box office and network expansion to support further gains.
How this was made
The 30-second read
Why it matters
The upgrade reflects confidence in IMAX's growth trajectory, potentially driving short‑term buying pressure.
Market read
Analyst target raise on a mid‑cap entertainment firm; may influence sector sentiment and short‑term price action.
What to watch
Potential supply‑chain constraints on screen installations and competition from streaming services could limit upside.
Background
Wedbush analysts increased IMAX's price target and EBITDA margin outlook after the company reported a 64% revenue jump and strong margin expansion in Q3.
Ticker impact
Wedbush raised its price target for IMAX to $62 and upgraded its 2026 EBITDA margin guidance, citing stronger earnings growth and margin expansion.
upward pressure as investors price in the higher target and improved margins
The new $62 target and 50%+ EBITDA margin guidance represent a material improvement over prior expectations, likely prompting buying interest.
Market effects
Higher IMAX guidance may boost sentiment for the cinema and entertainment exhibition sector.
U.S. entertainment stocks could see modest gains as the upgrade signals stronger demand for premium screen experiences.
Limited to markets where IMAX operates; no broad global impact.
Counterpoint
If box‑office growth stalls, the upgraded target could be premature, leading to a pull‑back.
Key entities
- AnalystWedbush
Equity research firm that raised IMAX's price target and guidance.
- CompanyIMAX Corp
Cinema technology and content provider.
